Guangzhou New Creative Bio Pharmaceutical

Guangzhou New Creative Bio-Pharmaceutical is a China-based biotechnology company focused on the research, development, and commercialization of innovative drugs for oncology and metabolic diseases. The company specializes in the development of targeted small molecule inhibitors and biological therapies, with a particular emphasis on next-generation kinase inhibitors for lung and colorectal cancers. Their pipeline includes several candidates in various stages of clinical development, aiming to address unmet medical needs in the Chinese and global markets. Headquartered in Guangzhou, the firm integrates drug discovery with advanced manufacturing capabilities to support its clinical programs. New Creative Bio-Pharmaceutical leverages strategic collaborations with academic institutions and clinical centers to accelerate its drug development timelines.